MNK Proteins as Therapeutic Targets in Leukemia

In leukemia, resistance to therapy is a major concern for survival. MAPK-interacting kinases (MNKs) have been identified as important activators of oncogenic-related signaling and may be mediators of resistance. Recent studies in leukemia models, especially acute myeloid leukemia (AML), have focused...

Descripción completa

Detalles Bibliográficos
Autores principales: Mazewski, Candice, Platanias, Leonidas C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10128080/
https://www.ncbi.nlm.nih.gov/pubmed/37113687
http://dx.doi.org/10.2147/OTT.S370874

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10128080/
https://www.ncbi.nlm.nih.gov/pubmed/37113687
http://dx.doi.org/10.2147/OTT.S370874

Ejemplares similares